Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-05-21 | Dr. Belanoff is a clinical faculty member and has expertise in clinical medicine and psychopharmacology; no software or programming experience mentioned. |
| 2013-04-17 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. He has expertise in clinical medicine and psychopharmacology. |
| 2014-04-07 | Dr. Belanoff is a clinical faculty member and has held various positions in psychiatry and behavioral sciences. He holds an M.D. from Columbia University. |
| 2015-04-20 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Our Board selected Dr. Belanoff to serve as a director because, as our Chief Executive Officer, he brings expertise and knowledge regarding our business and operations to our Board. Dr. Belanoff also has expertise in clinical medicine and psychopharmacology. |
| 2016-04-22 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. He has expertise in drug discovery, clinical medicine and psychopharmacology. |
| 2017-04-21 | Joseph K. Belanoff, M.D. is a co-founder of our company and has served as a member of our Board and as our Chief Executive Officer since 1999, and as our President since 2014. Dr. Belanoff is a clinical faculty member and has, since 1992, held various positions in the Department of Psychiatry and Behavioral Sciences at Stanford University. Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. |
| 2018-04-24 | Joseph K. Belanoff, M.D. is a co-founder of our company and has served as a member of our Board and our Chief Executive Officer since 1999, and as our President since 2014. Dr. Belanoff is a clinical faculty member at Stanford University (School of Medicine), where he has, since 1992, held various positions in the Department of Psychiatry and Behavioral Sciences. Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. |
| 2019-04-24 | Joseph K. Belanoff, M.D. is a co-founder of our company and has served as CEO and President since inception. He is an Adjunct Professor of Psychiatry at Stanford University and holds an M.D. from Columbia University. |
| 2020-04-27 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our research and development programs and commercial operations. He also has expertise in drug discovery and development and clinical medicine. |
| 2021-04-22 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our research and development programs and commercial operations. He also has expertise in drug discovery and development and clinical medicine. |
| 2022-04-25 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our research and development programs and commercial operations. He also has expertise in drug discovery and development and clinical medicine. |
| 2023-04-14 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our research and development programs and commercial operations. He also has expertise in drug discovery and development and clinical medicine. |
| 2024-04-10 | Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our research and development programs and commercial operations. He also has expertise in drug discovery and development and clinical medicine. |
Data sourced from SEC filings. Last updated: 2026-02-03